Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil

被引：17
|
作者：
Dias de Matos, Marcia Alves [1 ]
Ferreira, Renata Carneiro [1 ]
Rodrigues, Fabiana Perez [2 ]
Marinho, Tamiris Augusto [1 ]
Rodrigues Lopes, Carmen Luci [2 ]
Magalhaes Novais, Antonia Carlos [4 ]
Coimbra Motta-Castro, Ana Rita [3 ]
Teles, Sheila Araujo [2 ]
Dutra Souto, Francisco Jose [4 ]
Bringel Martins, Regina Maria [1 ]
机构：
[1] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil
[2] Univ Fed Goias, Fac Enfermagem, Goiania, Go, Brazil
[3] Univ Fed Mato Grosso do Sul, Dept Farm Bioquim, Campo Grande, MS, Brazil
[4] Univ Fed Mato Grosso, Fac Ciencias Med, Cuiaba, MT, Brazil
来源：
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2013年 / 108卷 / 03期
关键词：
hepatitis B virus; occult infection; genotypes; GENETIC DIVERSITY; VIRAL-HEPATITIS; HIGH PREVALENCE; RISK-FACTORS; GENOTYPES; EPIDEMIOLOGY;
D O I：
10.1590/S0074-02762013000300019
中图分类号：
R38 [医学寄生虫学]; Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ; 100103 ;
摘要：
The prevalence of occult hepatitis B virus (HBV) infection was investigated in 149 hepatitis B surface antigen (HBsAg) negative injecting drug users (IDUs) in the Central-West Region of Brazil. Of these individuals, 19 were positive for HBV DNA, resulting in an occult HBV infection prevalence of 12.7% (19/149); six of these 19 individuals had anti-HBV core and/or anti-HBV surface antibodies and 13 were negative for HBV markers. All IDUs with occult hepatitis B reported sexual and/or parenteral risk behaviours. All HBV DNA-positive samples were successfully genotyped. Genotype D was the most common (17/19), followed by genotype A (2/19). These findings reveal a high prevalence of occult HBV infection and the predominance of genotype D among IDUs in Brazil's Central-West Region.
引用
收藏
页码：386 / 389
页数：4
相关论文
共 50 条
  • [21] History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin
    Stark, K
    Bienzle, U
    Vonk, R
    Guggenmoos-Holzmann, I
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (06) : 1359 - 1366
  • [22] Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
    Des Jarlais, DC
    Diaz, T
    Perlis, T
    Vlahov, D
    Maslow, C
    Latka, M
    Rockwell, R
    Edwards, V
    Friedman, SR
    Monterroso, E
    Williams, I
    Garfein, RS
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (05) : 467 - 471
  • [23] Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users
    Levine, OS
    Vlahov, D
    Brookmeyer, R
    Cohn, S
    Nelson, KE
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03): : 579 - 583
  • [24] Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan
    Hsieh, Meng-Hsuan
    Wang, Shu-Chi
    Hsieh, Ming-Yen
    Huang, Chung-Feng
    Yeh, Ming-Lun
    Yang, Jeng-Fu
    Chang, Ko
    Lin, Wei-Ru
    Lin, Chun-Yu
    Chen, Tun-Chieh
    Huang, Jee-Fu
    Dai, Chia-Yen
    Tsai, Jih-Jin
    Chuang, Wan-Long
    Yu, Ming-Lung
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2016, 32 (10): : 526 - 530
  • [25] Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in Taiwan
    Chang, Sui-Yuan
    Yang, Chia-Ling
    Ko, Wei-Shin
    Liu, Wen-Chun
    Lin, Chi-Ying
    Wu, Cheng-Hsin
    Su, Yi-Chin
    Chang, Shu-Fang
    Chen, Mao-Yuan
    Sheng, Wang-Huei
    Hung, Chien-Ching
    Chang, Shan-Chwen
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (03) : 1083 - 1089
  • [26] An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users
    Spada, E
    Genovese, D
    Tosti, ME
    Mariano, A
    Cuccuini, M
    Proietti, L
    Di Giuli, C
    Lavagna, A
    Crapa, GE
    Morace, G
    Taffon, S
    Mele, A
    Rezza, G
    Rapicetta, M
    JOURNAL OF HEPATOLOGY, 2005, 43 (06) : 958 - 964
  • [27] Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users
    Brown, K
    Crofts, N
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1998, 22 (03) : 384 - 388
  • [28] Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users
    Grebely, Jason
    Matthews, Gail V.
    Hellard, Margaret
    Shaw, David
    van Beek, Ingrid
    Petoumenos, Kathy
    Alavi, Maryam
    Yeung, Barbara
    Haber, Paul S.
    Lloyd, Andrew R.
    Kaldor, John M.
    Dore, Gregory J.
    JOURNAL OF HEPATOLOGY, 2011, 55 (01) : 76 - 85
  • [29] HEPATITIS-C VIRUS-INFECTION AMONG A COHORT OF VICTORIAN INJECTING DRUG-USERS
    CROFTS, N
    HOPPER, JL
    BOWDEN, DS
    BRESCHKIN, AM
    MILNER, R
    LOCARNINI, SA
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (04) : 237 - 241
  • [30] Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention
    Hutchinson, SJ
    Bird, SM
    Taylor, A
    Goldberg, DJ
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2006, 17 (03) : 211 - 221
12345